Blockchain Registration Transaction Record

Cardio Diagnostics Combats Heart Disease with AI-Driven Precision Medicine

Cardio Diagnostics (CDIO) uses AI, epigenetics, and genetics for personalized cardiovascular disease detection and prevention. Learn about Epi+Gen CHD, PrecisionCHD, HeartRisk, and CardioInnovate360.

This news matters because cardiovascular disease remains the leading cause of death globally, yet current risk assessment tools often miss early signs or fail to personalize treatment. Cardio Diagnostics' AI-powered blood tests, such as Epi+Gen CHD and PrecisionCHD, could revolutionize how we detect and manage heart disease, offering earlier intervention and tailored therapies. For patients, this means potentially avoiding heart attacks and strokes; for healthcare systems, it promises cost savings through prevention. As the company advances its population health and biopharma solutions, the impact could extend to millions, reshaping cardiovascular care from reactive to proactive and precise.